Skip to main content
. 2022 Mar 16;12:4512. doi: 10.1038/s41598-022-08442-3

Figure 2.

Figure 2

Phenylbutyrate (PBA) treatment of corneal epithelial cells and bone-marrow-derived dendritic cells inhibits LPS-induced inflammation in vitro and the butyrate transporter SLC5A8 is required for this effect. (A) Corneal epithelial cells and (B) bone marrow dendritic cells (BMDC) were cultured from wild-type (WT) and Slc5a8 knockout (KO) mice, pretreated with either phenylbutyrate (PBA) or media control for 1 h, then left untreated (Untrt) or challenged with LPS. Each data point is a well with 1 tissue explant, and each condition was in duplicate or triplicate wells within each experiment. Shown is the combined qPCR data from the experiments after each dataset was normalized to the LPS-only treated condition. Mean ± standard deviation of three independent experiments; each experiment used 2–3 wells per condition. Statistical comparisons were made with two-way ANOVA using Tukey’s multiple comparisons test. P value greater than 0.05 was considered non-significant (ns). *P ≤ 0.5, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001.